Prof. Monilola Olayioye of the Institute of Cell Biology and Immunology (IZI) of the University of Stuttgart will coordinate the "3R-US" project. Together with Prof. Roland Kontermann (IZI) and Jun.-Prof. Michael Heymann (Institute of Biomaterials and Biomolecular Systems) and experts from the Robert-Bosch-Hospital in Stuttgart, the network will develop novel platforms for cancer research, relying on microfluidic tissue culture systems, biomaterials and simulations.